๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Polymorphisms inGSTM1,CYP1A1,CYP2E1, andCYP2D6are Associated with Susceptibility and Chemotherapy Response in Non-small-cell Lung Cancer Patients

โœ Scribed by WeiYing Li; WenTao Yue; LiNa Zhang; XiaoTing Zhao; Li Ma; XueHui Yang; ChunYan Zhang; Yue Wang; Meng Gu


Publisher
Springer
Year
2011
Tongue
English
Weight
218 KB
Volume
190
Category
Article
ISSN
0341-2040

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


CYP1A1 CYP2E1 and GSTM1 polymorphisms ar
โœ Shunji Morita; Masahiko Yano; Hitoshi Shiozaki; Toshimasa Tsujinaka; Chikara Ebi ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 43 KB ๐Ÿ‘ 1 views

We investigated the genetic polymorphisms of CYP1A1, CYP2E1 and GSTM1 in Japanese esophageal cancer patients (n = 53) with a histological diagnosis of squamous-cell carcinoma, to determine whether susceptibility to esophageal cancer is associated with these polymorphisms. There were no significant d

Associations of ABCB1, ABCC2, and ABCG2
โœ Ji-Youn Han; Hyeong-Seok Lim; Yeon-Kyeong Yoo; Eun Soon Shin; Yong Hoon Park; Su ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 215 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND. The authors investigated whether __ABCB1, ABCC2,__ and __ABCG2__ genetic polymorphisms affect pharmacokinetics (PK) of irinotecan and treatment outcome of patients with advanced nonsmall cell lung cancer (NSCLC). ## METHODS. Blood samples from 107 NSCLC patients treate

Infections in patients with non-small-ce
โœ Fuks, Joachim Z. ;Patel, Halesh ;Hornedo, Javier ;Van Echo, David A. ;Moody, Mar ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 612 KB

The records of 65 consecutive patients with non-small-cell lung cancer (NSCLC) treated with intensive induction chemotherapy were reviewed to study the infectious complications during therapy and to analyze the relationship of the frequency of infections to various predisposing factors. A total of 4